Serial Entrepreneurs Dale Pfost and David Weiner Bring Broad Expertise as AxoSim Expands Its Leadership in Human Organoid Technologies Designed to Make.
/PRNewswire/ Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment.
Bloomsbury Genetic Therapies launches with Seed financing of £5 million to develop potentially curative gene therapy treatments for rare neurological and metabolic diseasesLondon, UK, 7 October 2022 – Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a biotechnology company developin.
/PRNewswire/ Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, today announced the appointment of Chief.
Here, Thomas Rademacher of Emergex Vaccines explains how delivery of virus-specific major MHC class I epitopes to the skin-resident immune system can translate to the presence of antigen-specific memory T-cells at distal sites.